| GeneLibs

题目:: CCR 20th Anniversary Commentary: Divide and Conquer-Breast Cancer Subtypes and Response to Therapy.
作者:: Pusztai(Lajos),Rouzier(Roman),Symmans(W Fraser)
状态:: 发布时间2015-08-15 , 更新时间 2016-10-19
期刊:: Clin Cancer Res
摘要:: The article by Rouzier and colleagues, published in the August 15, 2005, issue of Clinical Cancer Research, demonstrated that different molecular subtypes of breast cancer have different degrees of sensitivity to chemotherapy, but the extent of response to neoadjuvant therapy has a different meaning by subtype. Several molecular subtype-specific clinical trials are under way to maximize pathologic complete response rates in triple-negative breast cancer and HER2-positive cancers, and to provide adjuvant treatment options for patients with residual invasive disease. See related article by Rouzier et al., Clin Cancer Res 2005;11(16) Aug 15, 2005;5678-85.
语言:: eng
DOI:: 10.1158/1078-0432.CCR-14-3121

文献库文献相关信息